Literature DB >> 30382420

Comparative Sleep Disturbances in Myotonic Dystrophy Types 1 and 2.

Andrea Romigi1, Valentina Franco2, Fabio Placidi3, Claudio Liguori3, Emanuele Rastelli3, Giuseppe Vitrani4, Diego Centonze4,3, Roberto Massa3.   

Abstract

PURPOSE OF REVIEW: To update current knowledge regarding sleep disturbances and myotonic dystrophies so as to better understand if sleep symptoms may help in the early recognition of the two genetic subtypes: myotonic dystrophy type 1 (DM1) and myotonic dystrophy type 2 (DM2). RECENT
FINDINGS: Sleep-disordered breathing (SDB), restless legs syndrome, periodic limb movements in sleep, hypersomnia, and REM sleep dysregulation are frequently described in DM1 patients. SDB does not always explain hypersomnia, but a central dysregulation of sleep-wake modulation is reported mainly in DM1. Sleep apnea, restless legs syndrome, and REM sleep without atonia have been reported in single case reports and small case series of DM2. DM2 is less prevalent and more recently described than DM1, with a milder phenotype than DM1. The most frequent sleep disorders in DM1 are hypersomnia, SDB, periodic limb movements, and a narcoleptic-like phenotype, whereas restless legs syndrome, SDB, and REM sleep without atonia seem to be the most frequent sleep disorders in DM2. Comparative sleep studies are strongly required to delineate the sleep phenotype of myotonic dystrophies.

Entities:  

Keywords:  Excessive daytime somnolence; Fatigue; Myotonic dystrophy type 1; Myotonic dystrophy type 2; Sleep; Sleep-disordered breathing

Mesh:

Year:  2018        PMID: 30382420     DOI: 10.1007/s11910-018-0903-x

Source DB:  PubMed          Journal:  Curr Neurol Neurosci Rep        ISSN: 1528-4042            Impact factor:   5.081


  88 in total

1.  Loss of serotonin-containing neurons in the raphe of patients with myotonic dystrophy: a quantitative immunohistochemical study and relation to hypersomnia.

Authors:  S Ono; K Takahashi; K Jinnai; F Kanda; Y Fukuoka; H Kurisaki; S Mitake; T Inagaki; T Yamano; K Nagao
Journal:  Neurology       Date:  1998-02       Impact factor: 9.910

2.  Proximal myotonic dystrophy--a family with autosomal dominant muscular dystrophy, cataracts, hearing loss and hypogonadism: heterogeneity of proximal myotonic syndromes?

Authors:  B Udd; R Krahe; C Wallgren-Pettersson; B Falck; H Kalimo
Journal:  Neuromuscul Disord       Date:  1997-06       Impact factor: 4.296

3.  Alveolar hypoventilation and hyperosmnia in myotonic dystrophy.

Authors:  G Coccagna; M Mantovani; C Parchi; F Mironi; E Lugaresi
Journal:  J Neurol Neurosurg Psychiatry       Date:  1975-10       Impact factor: 10.154

4.  REM behavior disorder in myotonic dystrophy type 2.

Authors:  Sudhansu Chokroverty; Sushanth Bhat; David Rosen; Amtul Farheen
Journal:  Neurology       Date:  2012-06-12       Impact factor: 9.910

5.  Predictors of disrupted social participation in myotonic dystrophy type 1.

Authors:  Cynthia Gagnon; Jean Mathieu; Stéphane Jean; Luc Laberge; Michel Perron; Suzanne Veillette; Louis Richer; Luc Noreau
Journal:  Arch Phys Med Rehabil       Date:  2008-07       Impact factor: 3.966

6.  [A marked decrease of orexin in the cerebrospinal fluid in a patient with myotonic dystrophy type 1 showing an excessive daytime sleepiness].

Authors:  Tomoaki Iwata; Naoki Suzuki; Hideki Mizuno; Ichiro Nakashima; Takashi Kanbayashi; Yasuto Itoyama
Journal:  Rinsho Shinkeigaku       Date:  2009-07

7.  Myotonic dystrophy type 2: human founder haplotype and evolutionary conservation of the repeat tract.

Authors:  Christina L Liquori; Yoshio Ikeda; Marcy Weatherspoon; Kenneth Ricker; Benedikt G H Schoser; Joline C Dalton; John W Day; Laura P W Ranum
Journal:  Am J Hum Genet       Date:  2003-09-22       Impact factor: 11.025

8.  Fatigue and daytime sleepiness in patients with myotonic dystrophy type 1: to lump or split?

Authors:  Luc Laberge; Yves Dauvilliers; Paul Bégin; Louis Richer; Stéphane Jean; Jean Mathieu
Journal:  Neuromuscul Disord       Date:  2009-04-29       Impact factor: 4.296

9.  Cardiac autonomic control during sleep in patients with myotonic dystrophy type 1: the effects of comorbid obstructive sleep apnea.

Authors:  Eleonora Tobaldini; Giorgio Colombo; Monica Solbiati; Chiara Cogliati; Lucia Morandi; Alessandro Pincherle; Nicola Montano
Journal:  Sleep Med       Date:  2017-09-05       Impact factor: 3.492

10.  Disruption of sleep-wake continuum in myotonic dystrophy type 1: Beyond conventional sleep staging.

Authors:  Enrica Bonanni; Luca Carnicelli; Davide Crapanzano; Michelangelo Maestri; Costanza Simoncini; Sigrid Baldanzi; Michela Falorni; Sergio Garbarino; Michelangelo Mancuso; Ubaldo Bonuccelli; Gabriele Siciliano
Journal:  Neuromuscul Disord       Date:  2018-02-12       Impact factor: 4.296

View more
  2 in total

1.  Sleep in Huntington's disease: a systematic review and meta-analysis of polysomongraphic findings.

Authors:  Ye Zhang; Rong Ren; Linghui Yang; Junying Zhou; Yun Li; Jie Shi; Lin Lu; Larry D Sanford; Xiangdong Tang
Journal:  Sleep       Date:  2019-10-09       Impact factor: 5.849

Review 2.  Sleep Complaints, Sleep and Breathing Disorders in Myotonic Dystrophy Type 2.

Authors:  Andrea Romigi; Michelangelo Maestri; Carmine Nicoletta; Giuseppe Vitrani; Marco Caccamo; Gabriele Siciliano; Enrica Bonanni; Diego Centonze; Alessandro Sanduzzi
Journal:  Curr Neurol Neurosci Rep       Date:  2019-02-09       Impact factor: 5.081

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.